- Home
- COLL vs CRON Comparison
COLL vs CRON Comparison
Compare COLL & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | CRON |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | COLL | CRON |
|---|---|---|
| Price | $21.84 | $3.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $49.00 | $3.67 |
| AVG Volume (30 Days) | ★ 751.9K | 679.9K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $780,567,000.00 | $146,587,000.00 |
| Revenue This Year | $7.25 | $39.82 |
| Revenue Next Year | $1.55 | $16.07 |
| P/E Ratio | ★ N/A | $27.92 |
| Revenue Growth | 23.62 | ★ 24.63 |
| 52 Week Low | $21.62 | $2.28 |
| 52 Week High | $50.79 | $3.61 |
Technical Indicators
Market Signals| Indicator | COLL | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 30.33 | 48.07 |
| Support Level | $21.65 | $2.51 |
| Resistance Level | $23.69 | $3.28 |
| Average True Range (ATR) | 0.87 | 0.10 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 17.87 | 44.59 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.